[1]
González Aldazabal, A., Goikolea Ugarte, F.J.G.U. and Alonso, E. 2025. Pembrolizumab: metastatic melanoma therapeutic option at the Integrated Health Organization Barrualde-Galdakao. Osagaiz: osasun-zientzien aldizkaria. 9, 1 (Apr. 2025). DOI:https://doi.org/10.26876/osagaiz.1.2025.3674.